Insiders Updates
HRTX Stock Sees Decline of Approximately -11.70% in Last Five Days
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Menu
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Heron Therapeutics Inc’s filing revealed that its EVP, Chief Development Officer Forbes William P acquired Company’s shares for reported $27250.0
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Heron Therapeutics Inc’s filing revealed that its EVP, Chief Development Officer Forbes William P acquired Company’s shares for reported $27250.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Heron Therapeutics
Heron Therapeutics Inc’s recent filing unveils that its EVP, Chief Development Officer Forbes William P acquired Company’s shares for reported
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Heron Therapeutics Inc’s recent filing unveils that its EVP, Chief Development Officer Forbes William P acquired Company’s shares for reported
Heron Therapeutics Inc. (NASDAQ: HRTX) stock surged by 11.38% at last close while the HRTX stock price gains by 7.53%